Color vision and contrast sensitivity in epilepsy patients treated with initial tiagabine monotherapy

Epilepsy Research

Volumn 67, Issue 3, 2005, Pages 101-107

  Sorri, Iiris ^a,b   Kälviäinen, Reetta ^a   Mäntyjärvi, Maija ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Antiepileptic drugs; Color vision; Contrast sensitivity; Tiagabine; Visual function

Indexed keywords

ANTICONVULSIVE AGENT; TIAGABINE;

ADULT; AGED; ANOMALOSCOPE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLOR VISION; COLOR VISION DEFECT; COLOR VISION TEST; CONTRAST SENSITIVITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOCAL EPILEPSY; HUMAN; MALE; MONOTHERAPY; OPTICAL INSTRUMENTATION; PRIORITY JOURNAL;

ADULT; AGED; ANTICONVULSANTS; COLOR PERCEPTION; CONTRAST SENSITIVITY; CROSS-SECTIONAL STUDIES; EPILEPSY; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MALE; MIDDLE AGED; NIPECOTIC ACIDS; VISION TESTS;

EID: 27944500239     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2005.09.002     Document Type: Article

References (35)

1. A. Bayer, H.J. Thiel, E. Zrenner, J. Dichgans, M. Kuehn, W. Paulus, S. Ried, and D. Schmidt Color vision tests for early detection of antiepileptic drug toxicity Neurology 48 1997 1394 1397
2. R.G. Beran, A. Hung, M. Plunkett, J. Currie, and T. Sachinwalla Predictability of visual field defects in patients exposed to GABAergic agents, vigabatrin, or tiagabine (abstract) Neurology 52 Suppl. 2 1999 A249
3. S.D. Collins, S. Brun, Y.G. Kirstein, and K.W. Sommerville Absence of visual field defects in patients taking tiagabine (Gabitril) (abstract) Epilepsia 39 Suppl. 6 1998 146 147
4. T. Eke, J.F. Talbot, and M.C. Lawden Severe persistent visual field constriction associated with vigabatrin BMJ 314 1997 180 181
5. T.A. Fakhoury, B. Abou-Khalil, P. Lavin, and K.W. Sommerville Lack of visual field defects with long-term use of tiagabine (abstract) Neurology 54 Suppl. 3 2000 309
6. D. Farnsworth The Farnsworth-Munsell 100-Hue Test 1957 Munsell Color Company Baltimore
7. A. Fink-Jensen, P.D. Suzdak, M.E. Swedberg, L. Judge, L. Hansen, and P.G. Nielsen The γ-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats Eur. J. Pharmacol. 220 1992 197 201
8. E.J. Hilton, S.L. Hosking, and T. Betts The effect of anti epileptic drugs on visual performance Seizure 13 2004 113 128
9. H. Ichikawa, K. Hukami, and S. Tanabe Standard Pseudoisochromatic Plates: Part 2 1983 Igaku-Shoin Ltd. Tokyo
10. R. Kälviäinen, M. Brodie, J. Duncan, D. Chadwick, D. Edwards, and K. Lydy For the Northern European Tiagabine Study Group 1998. A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures Epilepsy Res. 30 1998 31 40
11. R. Kälviäinen, I. Nousiainen, M. Mäntyjärvi, E. Nikoskelainen, J. Partanen, K. Partanen, and P. Riekkinen Sr. Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects Neurology 53 1999 922 926
12. K.R. Kaufman, F.E. Lepore, and B.J. Keyser Visual fields and tiagabine: a quandary Seizure 10 2001 525 529
13. P.R. Kinnear Proposals for scoring and assessing the 100-hue test Vision Res. 10 1970 423 433
14. G. Krauss, M. Johnson, and N. Miller Vigabatrin-associated retinal cone system dysfunction. Electroretinogram and ophthalmologic findings Neurology 50 1998 614 618
15. G. Krauss, M. Johnson, S. Sheth, and N. Miller A controlled study comparing visual function in patients treated with vigabatrin and tiagabine J. Neurol. Neurosurg. Psychiatr. 74 2003 339 343
16. ® (sildenafil citrate) and ophthalmology Progr. Ret. Eye Res. 13 21 2002 485 506
17. I.E. Leppik, L. Gram, R. Deaton, and K.W. Sommerville Safety of tiagabine: summary of 53 trials Epilepsy Res. 33 1999 235 246
18. L. López, A. Thomson, and A.L. Rabinowicz Assessment of colour vision in epileptic patients exposed to single-drug therapy Eur. Neurol. 41 1999 201 206
19. T. Maaranen, K. Tuppurainen, and M. Mäntyjärvi Color vision defects after central serous chorioretinopathy Retina 20 2000 633 637
20. M. Mäntyjärvi Normal test scores in the Farnsworth-Munsell 100 Hue Test Doc. Ophthalmol. 102 2001 73 80
21. M. Mäntyjärvi, and T.L. Laitinen Normal values of the Pelli-Robson contrast sensitivity test J. Cataract Refract. Surg. 27 2001 261 266
22. O. Mecarelli, S. Rinalduzzi, and N. Accornero Changes in color vision after a single dose of vigabatrin or carbamazepine in healthy volunteers Clin. Neuropharmacol. 24 2001 23 26
23. I. Nousiainen, M. Mäntyjärvi, and R. Kälviäinen Visual function in patients treated with the GABAergic anticonvulsant drug tiagabine Clin. Drug Invest. 20 2000 393 400
24. I. Nousiainen, R. Kälviäinen, and M. Mäntyjärvi Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy Ophthalmology 107 2000 884 888
25. I. Nousiainen, R. Kälviäinen, and M. Mäntyjärvi Contrast and glare sensitivity in epilepsy patients treated with vigabatrin or carbamazepine monotherapy compared with healthy volunteers Br. J. Ophthalmol. 84 2000 622 625
26. D. Pelli, J. Robson, and A. Wilkins The design of a new letter chart for measuring contrast sensitivity Clin. Vision Sci. 2 1988 187 199
27. M. Rosenthal Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control J. Clin. Psychiatry 64 2003 1245 1249
28. G. Rubin Reliability and sensitivity of clinical contrast sensitivity tests Clin. Vision Sci. 2 1988 169 217
29. S. Schachter Tiagabine monotherapy in the treatment of partial epilepsy Epilepsia 36 Suppl. 6 1995 S2 S6
30. G.J. Sills, P.N. Patsalos, E. Butler, G. Forrest, N. Ratnaraj, and M.J. Brodie Visual field constriction: accumulation of vigabatrin but not tiagabine in the retina Neurology 57 2001 196 200
31. V. Smith, J. Pokorny, and A. Pass Color-axis determination on the Farnsworth-Munsell 100-Hue Test Am. J. Ophthalmol. 100 1985 176 182
32. B. Steinhoff, N. Freudenthaler, and W. Paulus The influence of established and new antiepileptic drugs on visual perception. II. A controlled study in patients with epilepsy under long-term antiepileptic medication Epilepsy Res. 29 1997 49 58
33. P.D. Suzdak, and J.A. Jansen A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor Epilepsia 36 1995 612 626
34. G. Verriest, J. Van Laethem, and A. Uvijls A new assessment of the normal ranges of the Farnsworth-Munsell 100-Hue Test scores Am. J. Ophthalmol. 93 1982 635 642
35. A. Verrotti, L. Lobefalo, T. Priolo, M. Rapinese, D. Trotta, G. Morgese, P.E. Gallenga, and F. Chiarelli Color vision in epileptic adolescents treated with valproate and carbamazepine Seizure 13 2004 411 417